H&F Corporate Investors VII, Ltd. - 08 Dec 2021 Form 4 Insider Report for PPD, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
08 Dec 2021, 15:53:26 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
H&F CORPORATE INVESTORS VII, LTD. By: /s/ Allen R. Thorpe Name: Allen R. Thorpe Title: Vice President

Key filing fact

H&F Corporate Investors VII, Ltd. filed Form 4 for PPD, Inc. on 08 Dec 2021.

Key facts

  • This page summarizes H&F Corporate Investors VII, Ltd.'s Form 4 filing for PPD, Inc..
  • 9 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Dec 2021, 15:53.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$6,309,960,135.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PPD transaction

Common Stock

Sale

Transaction value
$2,511,991,710
Shares
-52,884,036
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F2, F11
PPD transaction

Common Stock

Sale

Transaction value
$961,608,382
Shares
-20,244,387
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F3, F11
PPD transaction

Common Stock

Sale

Transaction value
$172,460,150
Shares
-3,630,740
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F4, F11
PPD transaction

Common Stock

Sale

Transaction value
$17,070,170
Shares
-359,372
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F5, F11
PPD transaction

Common Stock

Sale

Transaction value
$1,692,065,378
Shares
-35,622,429
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F6, F11
PPD transaction

Common Stock

Sale

Transaction value
$759,401,928
Shares
-15,987,409
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F7, F11
PPD transaction

Common Stock

Sale

Transaction value
$143,511,085
Shares
-3,021,286
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F8, F11
PPD transaction

Common Stock

Sale

Transaction value
$44,387,278
Shares
-934,469
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F9, F11
PPD transaction

Common Stock

Sale

Transaction value
$7,464,055
Shares
-157,138
Change %
-100%
Price
$47.50
Shares after
0
Date
08 Dec 2021
Ownership
See Footnotes
Footnotes
F1, F10, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

H&F Corporate Investors VII, Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 11 footnotes

Footnote F1

On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.

Footnote F2

Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").

Footnote F3

Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").

Footnote F4

Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").

Footnote F5

Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").

Footnote F6

Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

Footnote F7

Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

Footnote F8

Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").

Footnote F9

Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

Footnote F10

Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

Footnote F11

Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.

SEC remarks

Because no more than 10 reporting persons can file any one Form 4 through the Securities and Exchange Commission's EDGAR system, certain affiliates of the Reporting Persons have filed a separate Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .